Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Thermo Scientific™ B·R·A·H·M·S™ PlGF plus KRYPTOR™

Catalog No. 21279213
Change view
Click to view available options
Type:
Calibrator
Controls
Immunofluorescent Assay
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Type
21-279-213 Immunofluorescent Assay
21-279-211 Calibrator
21-279-212 Controls
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
This item is not returnable. View return policy
Catalog No. 21-279-213
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

B·R·A·H·M·S provides a complete portfolio of biomarkers for the most reliable results in prenatal screening. Improve pre-eclampsia management from first to third trimester of pregnancy with B·R·A·H·M·S PlGF plus KRYPTOR and get results in less than 30 minutes.

B·R·A·H·M·S provides a complete portfolio of biomarkers for the management of pre-eclampsia throughout the pregnancy. B·R·A·H·M·S PlGF plus KRYPTOR is indicated as an aid for the early identification of women at risk of early onset pre-eclampsia in the first trimester, and with B·R·A·H·M·S sFlt-1 KRYPTOR, as aid for early prediction, diagnosis, and prognosis of pre-clampsia from week 20 and an identification of women at risk of developing term pre-eclampsia at week 36. The B·R·A·H·M·S PlGF plus KRYPTOR test is also indicated as an aid to be used in conjunction with the clinical evaluation for non-invasive risk assessment of fetal trisomy 21 in first trimester in pregnant women. Get confidence in your results with the high precision of B·R·A·H·M·S PlGF plus KRYPTOR and get results in less than 30 minutes.

  • The most complete intended uses for the management of pre-eclampsia in pregnancy with B·R·A·H·M·S PlGF plus KRYPTOR
  • Suitable for screening of pre-term pre-eclampsia between week 11 and 14
  • Suitable for short-term prediction, diagnosis and prognosis of pre-eclampsia from week 20 of pregnancy with sFlt-1/PlGF ratio
  • Suitable for screening for term pre-eclampsia at week 36 of pregnancy in combination with sFlt-1
  • Suitable for screening for trisomy 21 in first trimester in combination with PAPP-A, Free βhCG and AFP
  • Short incubation time with only 29 minutes for a short turnaround time
  • Allows measurement in serum and plasma (EDTA)
  • Large capacity with 75 tests
  • Kit stable up to 29 days after opening onboard the instrument
  • Easy workflow with only 1 calibrator and one calibration every 2 weeks
  • Fits your throughput need with B·R·A·H·M·S KRYPTOR compact PLUS or B·R·A·H·M·S KRYPTOR GOLD
  • Easy to use with sFlt-1/PlGF ratio calculated by the instrument
  • Allows risk calculation in first trimester with B·R·A·H·M·S Fast screen pre I plus
TRUSTED_SUSTAINABILITY

Specifications

Detectable Analytes PlGF
Detection Method Immunofluorescence
Sample Type Serum, plasma (EDTA)
Type Immunofluorescent Assay
For Use With (Application) Forr quantitative determination of Placental Growth Factor (PlGF). Aid in diagnosis of pre-eclampsia, short-term prognosis of pre-eclampsia, risk assessement of developing pre-eclampsia in first, second and third trimester of pregnancy, risk assessement of fetal trisomy 21 in first trimester of pregnancy
Includes Kit for 75 determinations
Analysis Time 29 minutes
Form Lyophilized

Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.